CHEMED CORP (CHE) Fundamental Analysis & Valuation
NYSE:CHE • US16359R1032
Current stock price
399.34 USD
+1.01 (+0.25%)
At close:
399.34 USD
0 (0%)
After Hours:
This CHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CHE Profitability Analysis
1.1 Basic Checks
- CHE had positive earnings in the past year.
- In the past year CHE had a positive cash flow from operations.
- CHE had positive earnings in each of the past 5 years.
- Each year in the past 5 years CHE had a positive operating cash flow.
1.2 Ratios
- CHE has a better Return On Assets (17.24%) than 100.00% of its industry peers.
- The Return On Equity of CHE (27.08%) is better than 92.08% of its industry peers.
- The Return On Invested Capital of CHE (21.08%) is better than 95.05% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for CHE is significantly above the industry average of 8.92%.
- The last Return On Invested Capital (21.08%) for CHE is above the 3 year average (21.04%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.24% | ||
| ROE | 27.08% | ||
| ROIC | 21.08% |
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
1.3 Margins
- CHE's Profit Margin of 10.48% is amongst the best of the industry. CHE outperforms 96.04% of its industry peers.
- CHE's Profit Margin has declined in the last couple of years.
- With an excellent Operating Margin value of 14.01%, CHE belongs to the best of the industry, outperforming 86.14% of the companies in the same industry.
- CHE's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 32.54%, CHE is in the better half of the industry, outperforming 63.37% of the companies in the same industry.
- In the last couple of years the Gross Margin of CHE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.01% | ||
| PM (TTM) | 10.48% | ||
| GM | 32.54% |
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
2. CHE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
- The number of shares outstanding for CHE has been reduced compared to 1 year ago.
- The number of shares outstanding for CHE has been reduced compared to 5 years ago.
- CHE has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 11.01 indicates that CHE is not in any danger for bankruptcy at the moment.
- CHE's Altman-Z score of 11.01 is amongst the best of the industry. CHE outperforms 97.03% of its industry peers.
- CHE has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 0.03, CHE belongs to the top of the industry, outperforming 93.07% of the companies in the same industry.
- A Debt/Equity ratio of 0.01 indicates that CHE is not too dependend on debt financing.
- CHE has a better Debt to Equity ratio (0.01) than 84.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Altman-Z | 11.01 |
ROIC/WACC2.37
WACC8.88%
2.3 Liquidity
- CHE has a Current Ratio of 1.05. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.05, CHE is not doing good in the industry: 64.36% of the companies in the same industry are doing better.
- A Quick Ratio of 1.03 indicates that CHE should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.03, CHE is doing worse than 61.39% of the companies in the same industry.
- The current and quick ratio evaluation for CHE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.03 |
3. CHE Growth Analysis
3.1 Past
- CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.70%.
- CHE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.61% yearly.
- CHE shows a small growth in Revenue. In the last year, the Revenue has grown by 4.06%.
- Measured over the past years, CHE shows a small growth in Revenue. The Revenue has been growing by 4.00% on average per year.
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
3.2 Future
- The Earnings Per Share is expected to grow by 10.57% on average over the next years. This is quite good.
- The Revenue is expected to grow by 5.60% on average over the next years.
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. CHE Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 18.50, which indicates a rather expensive current valuation of CHE.
- Based on the Price/Earnings ratio, CHE is valued a bit cheaper than the industry average as 72.28% of the companies are valued more expensively.
- CHE is valuated rather cheaply when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 16.47 indicates a correct valuation of CHE.
- Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than the industry average as 72.28% of the companies are valued more expensively.
- CHE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.12, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.5 | ||
| Fwd PE | 16.47 |
4.2 Price Multiples
- CHE's Enterprise Value to EBITDA ratio is in line with the industry average.
- 69.31% of the companies in the same industry are more expensive than CHE, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.89 | ||
| EV/EBITDA | 12.94 |
4.3 Compensation for Growth
- CHE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of CHE may justify a higher PE ratio.
PEG (NY)1.5
PEG (5Y)5.12
EPS Next 2Y12.04%
EPS Next 3Y10.57%
5. CHE Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.60%, CHE is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.50, CHE pays a better dividend. On top of this CHE pays more dividend than 82.18% of the companies listed in the same industry.
- With a Dividend Yield of 0.60, CHE pays less dividend than the S&P500 average, which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.6% |
5.2 History
- The dividend of CHE is nicely growing with an annual growth rate of 11.06%!
- CHE has paid a dividend for at least 10 years, which is a reliable track record.
- CHE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.06%
Div Incr Years16
Div Non Decr Years21
5.3 Sustainability
- CHE pays out 11.95% of its income as dividend. This is a sustainable payout ratio.
- The dividend of CHE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP11.95%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
CHE Fundamentals: All Metrics, Ratios and Statistics
399.34
+1.01 (+0.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25 2026-02-25/amc
Earnings (Next)04-21 2026-04-21
Inst Owners101.6%
Inst Owner Change42.44%
Ins Owners1.54%
Ins Owner Change-1.94%
Market Cap5.50B
Revenue(TTM)2.53B
Net Income(TTM)265.24M
Analysts75
Price Target566.61 (41.89%)
Short Float %3.43%
Short Ratio2.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.6% |
Yearly Dividend2.24
Dividend Growth(5Y)11.06%
DP11.95%
Div Incr Years16
Div Non Decr Years21
Ex-Date02-23 2026-02-23 (0.6)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.47%
Min EPS beat(2)-10.06%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-6.89%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)1
Avg EPS beat(8)-5.02%
EPS beat(12)3
Avg EPS beat(12)-3.1%
EPS beat(16)7
Avg EPS beat(16)-1.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.96%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)2
Avg Revenue beat(16)-1.4%
PT rev (1m)0%
PT rev (3m)-3.27%
EPS NQ rev (1m)-8.48%
EPS NQ rev (3m)-8.48%
EPS NY rev (1m)-5.51%
EPS NY rev (3m)-5.76%
Revenue NQ rev (1m)-2.43%
Revenue NQ rev (3m)-2.43%
Revenue NY rev (1m)-1.24%
Revenue NY rev (3m)-1.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.5 | ||
| Fwd PE | 16.47 | ||
| P/S | 2.17 | ||
| P/FCF | 16.89 | ||
| P/OCF | 14.16 | ||
| P/B | 5.61 | ||
| P/tB | 23.95 | ||
| EV/EBITDA | 12.94 |
EPS(TTM)21.59
EY5.41%
EPS(NY)24.25
Fwd EY6.07%
FCF(TTM)23.64
FCFY5.92%
OCF(TTM)28.2
OCFY7.06%
SpS183.73
BVpS71.13
TBVpS16.68
PEG (NY)1.5
PEG (5Y)5.12
Graham Number185.88
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.24% | ||
| ROE | 27.08% | ||
| ROCE | 28.33% | ||
| ROIC | 21.08% | ||
| ROICexc | 22.41% | ||
| ROICexgc | 60.78% | ||
| OM | 14.01% | ||
| PM (TTM) | 10.48% | ||
| GM | 32.54% | ||
| FCFM | 12.86% |
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
ROICexc(3y)24.14%
ROICexc(5y)24.65%
ROICexgc(3y)64.18%
ROICexgc(5y)68.12%
ROCE(3y)28.21%
ROCE(5y)29.9%
ROICexgc growth 3Y-2.67%
ROICexgc growth 5Y-7.4%
ROICexc growth 3Y-2.26%
ROICexc growth 5Y-2.45%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
F-Score6
Asset Turnover1.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Debt/EBITDA | 0.03 | ||
| Cap/Depr | 96.84% | ||
| Cap/Sales | 2.48% | ||
| Interest Coverage | 263.51 | ||
| Cash Conversion | 92.61% | ||
| Profit Quality | 122.71% | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 11.01 |
F-Score6
WACC8.88%
ROIC/WACC2.37
Cap/Depr(3y)89.6%
Cap/Depr(5y)92.99%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.49%
Profit Quality(3y)114.97%
Profit Quality(5y)107.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
Revenue Next Year4.74%
Revenue Next 2Y5.44%
Revenue Next 3Y5.6%
Revenue Next 5YN/A
EBIT growth 1Y-12.87%
EBIT growth 3Y1.18%
EBIT growth 5Y1.52%
EBIT Next Year25.84%
EBIT Next 3Y13.68%
EBIT Next 5YN/A
FCF growth 1Y-11.55%
FCF growth 3Y8.82%
FCF growth 5Y-5.44%
OCF growth 1Y-7%
OCF growth 3Y7.8%
OCF growth 5Y-4.52%
CHEMED CORP / CHE Fundamental Analysis FAQ
What is the fundamental rating for CHE stock?
ChartMill assigns a fundamental rating of 7 / 10 to CHE.
What is the valuation status of CHEMED CORP (CHE) stock?
ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.
Can you provide the profitability details for CHEMED CORP?
CHEMED CORP (CHE) has a profitability rating of 8 / 10.
Can you provide the financial health for CHE stock?
The financial health rating of CHEMED CORP (CHE) is 8 / 10.
What is the earnings growth outlook for CHEMED CORP?
The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to grow by 12.32% in the next year.